Callan Family Office LLC Invests $2.71 Million in Hawkins, Inc. $HWKN

Callan Family Office LLC bought a new stake in Hawkins, Inc. (NASDAQ:HWKN - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 19,089 shares of the specialty chemicals company's stock, valued at approximately $2,713,000. Callan Family Office LLC owned 0.09% of Hawkins as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in shares of Hawkins during the 2nd quarter worth approximately $449,055,000. Vanguard Group Inc. raised its stake in shares of Hawkins by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 1,525,789 shares of the specialty chemicals company's stock valued at $216,754,000 after purchasing an additional 20,958 shares in the last quarter. State Street Corp raised its stake in shares of Hawkins by 11.6% in the fourth quarter. State Street Corp now owns 1,067,451 shares of the specialty chemicals company's stock valued at $151,642,000 after purchasing an additional 111,318 shares in the last quarter. Wasatch Advisors LP lifted its position in Hawkins by 31.4% in the fourth quarter. Wasatch Advisors LP now owns 552,419 shares of the specialty chemicals company's stock worth $78,477,000 after purchasing an additional 131,850 shares during the period. Finally, Geode Capital Management LLC lifted its position in Hawkins by 2.8% in the fourth quarter. Geode Capital Management LLC now owns 513,535 shares of the specialty chemicals company's stock worth $72,965,000 after purchasing an additional 13,828 shares during the period. 69.71% of the stock is owned by institutional investors and hedge funds.

Hawkins Price Performance

Hawkins stock opened at $118.99 on Friday. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.27 and a quick ratio of 1.54. The company has a market capitalization of $2.48 billion, a PE ratio of 30.83, a price-to-earnings-growth ratio of 2.45 and a beta of 0.79. Hawkins, Inc. has a one year low of $117.98 and a one year high of $186.15. The business has a 50 day simple moving average of $140.27 and a 200 day simple moving average of $147.56.

Hawkins (NASDAQ:HWKN - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The specialty chemicals company reported $1.35 EPS for the quarter, missing the consensus estimate of $1.39 by ($0.04). Hawkins had a net margin of 7.29% and a return on equity of 15.42%. The company had revenue of $315.68 million during the quarter, compared to analyst estimates of $313.42 million. On average, sell-side analysts forecast that Hawkins, Inc. will post 4.04 EPS for the current fiscal year.

Hawkins Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 28th. Stockholders of record on Friday, August 14th will be paid a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Friday, August 14th. Hawkins's payout ratio is currently 20.73%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Zacks Research lowered shares of Hawkins from a "hold" rating to a "strong sell" rating in a report on Tuesday, August 4th. BWS Financial reaffirmed a "buy" rating and set a $200.00 price objective on shares of Hawkins in a report on Monday, August 3rd. Weiss Ratings lowered shares of Hawkins from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Tuesday, July 14th. Finally, Barclays set a $142.00 target price on shares of Hawkins and gave the company an "equal weight" rating in a research note on Friday, July 31st. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $171.00.

About Hawkins

Hawkins, Inc NASDAQ: HWKN is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins' product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.

Want to see what other hedge funds are holding HWKN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hawkins, Inc. (NASDAQ:HWKN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source